AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
Familial cerebral amyloid angiopathy related to stroke and dementia
Authors: Frangione, B Revesz, T Vidal, R Holton, J Lashley, T Houlden, H Wood, N Rostagno, A Plant, G Ghiso, J
Citation: B. Frangione et al., Familial cerebral amyloid angiopathy related to stroke and dementia, AMYLOID, 8, 2001, pp. 36-42
Sequence, genomic structure and tissue expression of Human BRI3, a member of the BRI gene family
Authors: Vidal, R Calero, M Revesz, T Plant, G Ghiso, J Frangione, B
Citation: R. Vidal et al., Sequence, genomic structure and tissue expression of Human BRI3, a member of the BRI gene family, GENE, 266(1-2), 2001, pp. 95-102
Distinct properties of wild-type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type
Authors: Calero, M Pawlik, M Soto, C Castano, EM Sigurdsson, EM Kumar, A Gallo, G Frangione, B Levy, E
Citation: M. Calero et al., Distinct properties of wild-type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type, J NEUROCHEM, 77(2), 2001, pp. 628-637
A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Straussler-Scheinker disease A117V
Authors: Tagliavini, F Lievens, PMJ Tranchant, C Warter, JM Mohr, M Giaccone, G Perini, F Rossi, G Salmona, M Piccardo, P Ghetti, B Beavis, RC Bugiani, O Frangione, B Prelli, F
Citation: F. Tagliavini et al., A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Straussler-Scheinker disease A117V, J BIOL CHEM, 276(8), 2001, pp. 6009-6015
Systemic amyloid deposits in familial British dementia
Authors: Ghiso, JA Holton, J Miravalle, L Calero, M Lashley, T Vidal, R Houlden, H Wood, N Neubert, TA Rostagno, A Plant, G Revesz, T Frangione, B
Citation: Ja. Ghiso et al., Systemic amyloid deposits in familial British dementia, J BIOL CHEM, 276(47), 2001, pp. 43909-43914
Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid A beta peptide
Authors: Poeggeler, B Miravalle, L Zagorski, MG Wisniewski, T Chyan, YJ Zhang, YB Shao, HY Bryant-Thomas, T Vidal, R Frangione, B Ghiso, J Pappolla, MA
Citation: B. Poeggeler et al., Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid A beta peptide, BIOCHEM, 40(49), 2001, pp. 14995-15001
Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice
Authors: Sigurdsson, EM Scholtzova, H Mehta, PD Frangione, B Wisniewski, T
Citation: Em. Sigurdsson et al., Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice, AM J PATH, 159(2), 2001, pp. 439-447
Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia
Authors: Holton, JL Ghiso, J Lashley, T Rostagno, A Guerin, CJ Gibb, G Houlden, H Ayling, H Martinian, L Anderton, BH Wood, NW Vidal, R Plant, G Frangione, B Revesz, T
Citation: Jl. Holton et al., Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia, AM J PATH, 158(2), 2001, pp. 515-526
Familial British dementia
Authors: Ghiso, J Revesz, T Rostagno, A Vidal, RG Plant, G Frangione, B
Citation: J. Ghiso et al., Familial British dementia, ALZHEIMER'S DISEASE, 2001, pp. 487-493
A decamer duplication in the BRI gene originates a de novo amyloid peptidethat causes dementia in a Danish kindred
Authors: Vidal, RG Revesz, T Rostagno, A Bek, T Braendgaard, H Plant, G Ghiso, J Frangione, B
Citation: Rg. Vidal et al., A decamer duplication in the BRI gene originates a de novo amyloid peptidethat causes dementia in a Danish kindred, ALZHEIMER'S DISEASE, 2001, pp. 507-513
Conformation as therapeutic target in the prionoses and other neurodegenerative conditions
Authors: Wisniewski, T Sigurdsson, EM Aucouturier, P Frangione, B
Citation: T. Wisniewski et al., Conformation as therapeutic target in the prionoses and other neurodegenerative conditions, METH MOL M, 59, 2001, pp. 223-236
New familial forms of cerebral amyloid and dementia
Authors: Vidal, R Ghiso, J Frangione, B
Citation: R. Vidal et al., New familial forms of cerebral amyloid and dementia, MOL PSYCHI, 5(6), 2000, pp. 575-576
Clearance of amyloid beta-peptide from brain: transport or metabolism?
Authors: Zlokovic, BV Yamada, S Holtzman, D Ghiso, J Frangione, B
Citation: Bv. Zlokovic et al., Clearance of amyloid beta-peptide from brain: transport or metabolism?, NAT MED, 6(7), 2000, pp. 718-718
Apolipoprotein J (clusterin) and Alzheimer's disease
Authors: Calero, M Rostagno, A Matsubara, E Zlokovic, B Frangione, B Ghiso, J
Citation: M. Calero et al., Apolipoprotein J (clusterin) and Alzheimer's disease, MICROSC RES, 50(4), 2000, pp. 305-315
Familial cerebral amyloid angiopathies and dementia
Authors: Frangione, B Vidal, R Rostagno, A Ghiso, J
Citation: B. Frangione et al., Familial cerebral amyloid angiopathies and dementia, ALZ DIS A D, 14, 2000, pp. S25-S30
Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele
Authors: Askanas, V Engel, WK Alvarez, RB Frangione, B Ghiso, J Vidal, R
Citation: V. Askanas et al., Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele, ANN NEUROL, 47(4), 2000, pp. 544-549
An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease
Authors: Pappolla, MA Chyan, YJ Poeggeler, B Frangione, B Wilson, G Ghiso, J Reiter, RJ
Citation: Ma. Pappolla et al., An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease, J NEURAL TR, 107(2), 2000, pp. 203-231
Lipidation of apolipoprotein E influences its isoform-specific interactionwith Alzheimer's amyloid beta peptides
Authors: Tokuda, T Calero, M Matsubara, E Vidal, R Kumar, A Permanne, B Zlokovic, B Smith, JD Ladu, MJ Rostagno, A Frangione, B Ghiso, J
Citation: T. Tokuda et al., Lipidation of apolipoprotein E influences its isoform-specific interactionwith Alzheimer's amyloid beta peptides, BIOCHEM J, 348, 2000, pp. 359-365
Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides
Authors: Soto, C Kascsak, RJ Saborio, GP Aucouturier, P Wisniewski, T Prelli, F Kascsak, R Mendez, E Harris, DA Ironside, J Tagliavini, F Carp, RI Frangione, B
Citation: C. Soto et al., Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides, LANCET, 355(9199), 2000, pp. 192-197
A decamer duplication in the 3 ' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred
Authors: Vidal, R Revesz, T Rostagno, A Kim, E Holton, JL Bek, T Bojsen-Moller, M Braendgaard, H Plant, G Ghiso, J Frangione, B
Citation: R. Vidal et al., A decamer duplication in the 3 ' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred, P NAS US, 97(9), 2000, pp. 4920-4925
In vivo reversal of amyloid-beta lesions in rat brain
Authors: Sigurdsson, EM Permanne, B Soto, C Wisniewski, T Frangione, B
Citation: Em. Sigurdsson et al., In vivo reversal of amyloid-beta lesions in rat brain, J NE EXP NE, 59(1), 2000, pp. 11-17
In vitro evidence that beta-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability
Authors: Strazielle, N Ghersi-Egea, JF Ghiso, J Dehouck, MP Frangione, B Patlak, C Fenstermacher, J Gorevic, P
Citation: N. Strazielle et al., In vitro evidence that beta-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability, J NE EXP NE, 59(1), 2000, pp. 29-38
Clearance of Alzheimer's amyloid-beta(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
Authors: Shibata, M Yamada, S Kumar, SR Calero, M Bading, J Frangione, B Holtzman, DM Miller, CA Strickland, DK Ghiso, J Zlokovic, BV
Citation: M. Shibata et al., Clearance of Alzheimer's amyloid-beta(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier, J CLIN INV, 106(12), 2000, pp. 1489-1499
Substitutions at codon 22 of Alzheimer's A beta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells
Authors: Miravalle, L Tokuda, T Chiarle, R Giaccone, G Bugiani, O Tagliavini, F Frangione, B Ghiso, J
Citation: L. Miravalle et al., Substitutions at codon 22 of Alzheimer's A beta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells, J BIOL CHEM, 275(35), 2000, pp. 27110-27116
Fasciola hepatica: Parasite-secreted proteinases degrade all human IgG subclasses: Determination of the specific cleavage sites and identification ofthe immunoglobulin fragments produced
Authors: Berasain, P Carmona, C Frangione, B Dalton, JP Goni, F
Citation: P. Berasain et al., Fasciola hepatica: Parasite-secreted proteinases degrade all human IgG subclasses: Determination of the specific cleavage sites and identification ofthe immunoglobulin fragments produced, EXP PARASIT, 94(2), 2000, pp. 99-110
Risultati: 1-25 | 26-44